As of 2026-09-17, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (68.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.00 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -1466.2%.
The range of the Relative Valuation is (43.10) - (80.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 21.4x | 18.8x |
| Forward P/E multiples | 10.8x - 20.2x | 15.5x |
| Fair Price | (43.10) - (80.38) | (68.31) |
| Upside | -962.0% - -1707.6% | -1466.2% |
| Date | P/E |
| 2026-09-16 | -1.26 |
| 2026-09-15 | -1.25 |
| 2026-09-14 | -1.29 |
| 2026-09-11 | -1.28 |
| 2026-09-10 | -1.27 |
| 2026-09-09 | -1.32 |
| 2026-09-08 | -1.34 |
| 2026-09-04 | -1.36 |
| 2026-09-03 | -1.34 |
| 2026-09-02 | -1.39 |
| 2026-09-01 | -1.36 |
| 2026-08-31 | -1.36 |
| 2026-08-28 | -1.33 |
| 2026-08-27 | -1.37 |
| 2026-08-26 | -1.34 |
| 2026-08-25 | -1.37 |
| 2026-08-24 | -1.34 |
| 2026-08-21 | -1.33 |
| 2026-08-20 | -1.35 |
| 2026-08-19 | -1.40 |
| 2026-08-18 | -1.37 |
| 2026-08-17 | -1.32 |
| 2026-08-14 | -1.31 |
| 2026-08-13 | -1.26 |
| 2026-08-12 | -1.30 |
| 2026-08-11 | -1.24 |
| 2026-08-10 | -1.26 |
| 2026-08-07 | -1.26 |
| 2026-08-06 | -1.28 |
| 2026-08-05 | -1.28 |
| 2026-08-04 | -1.34 |
| 2026-08-03 | -1.31 |
| 2026-07-31 | -1.28 |
| 2026-07-30 | -1.30 |
| 2026-07-29 | -1.27 |
| 2026-07-28 | -1.30 |
| 2026-07-27 | -1.31 |
| 2026-07-24 | -1.30 |
| 2026-07-23 | -1.35 |
| 2026-07-22 | -1.34 |
| 2026-07-21 | -1.38 |
| 2026-07-20 | -1.34 |
| 2026-07-17 | -1.37 |
| 2026-07-16 | -1.37 |
| 2026-07-15 | -1.47 |
| 2026-07-14 | -1.47 |
| 2026-07-13 | -1.51 |
| 2026-07-10 | -1.57 |
| 2026-07-09 | -1.60 |
| 2026-07-08 | -1.65 |